Stocks and Investing Stocks and Investing
Mon, March 19, 2012

Sunpeaks Ventures Announces Clotamin to be Sold at Sedano's Stores in Florida


Published on 2012-03-19 06:11:07 - Market Wire
  Print publication without navigation


Sunpeaks Ventures Announces Clotamin to be Sold at Sedano's Stores in... -- SILVER SPRING, Md., March 19, 2012 /PRNewswire/ --

Sunpeaks Ventures Announces Clotamin to be Sold at Sedano's Stores in Florida

SILVER SPRING, Md., March 19, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialist, LLC ("HDS") are pleased to announce that Clotamin® will soon be available at Sedano's Supermarkets across South and Central Florida.

Sedano's Supermarkets was founded in Hialeah, Florida in 1962.   From its humble beginnings with a single store, the Sedano's chain has grown to more than 34 supermarkets across South and Central Florida.  Sedano's is now the No. 1 Hispanic-owned retailer in the United States and also the largest member of the Associated Grocers of Florida.  The company is currently preparing for its milestone 50th anniversary, taking place in 2012, which will include the beautification of all Sedano's stores.

"The addition of this established regional retailers adds to the growing list of Clotamin distributors and should be a boost for expanding and sustaining Clotamin sales in the South and Central Florida region," stated Mackie A. Barch, CEO of Sunpeaks.  "This successful and trusted retailer has built long standing relationships within the local communities that they serve so well.  We look forward to working closely with them to introduce Clotamin to their many loyal customers and achieving sales to a new customer base."

Clotamin® is the world's first specialized OTC multivitamin product designed exclusively for use by patients on Warfarin® or other anticoagulants (blood thinners).  According to BioMed Trends, in a report released by Global Industry Analysts, Inc., the global anticoagulants market is projected to surpass $11.2 billion by the year 2015, driven by an aging global population, rising incidence of cardiovascular diseases, cancers, and acute hip and knee complications, as well as emergence of innovative therapeutics targeting new and previously targeted clotting factors.

About Sunpeaks Ventures, Inc.

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market.   HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.

For additional information, please visit [ www.sunpeaksventures.com ].

Contact: Financial Insights 888-248-8491 or [ info@sunpeaksventures.com ]

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The words "forecast," "anticipate," "estimate," "project," "intend," "expect," "should," "believe," and similar expressions are intended to identify forward-looking statements.  These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements.  The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission.  All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement.  Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.

 

SOURCE Sunpeaks Ventures, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.sunpeaksventures.com ]

Contributing Sources